Artigo Científico

The influence of demography and referral medical specialty on the detection of autoantibodies to HEP-2 cells in a large sample of patients

Publicado em: Aug 2022

Autores

  • Wilton Ferreira Silva Santos
    Immunology Division, Sabin Diagnostic Medicine, SAAN QUADRA 03 Lote - 165 Térreo, Brasília, DF, CEP: 70632-300, Brazil. wiltonss@uol.com.br.
  • Ana Paula de Castro Cantuária
    Immunology Division, Sabin Diagnostic Medicine, SAAN QUADRA 03 Lote - 165 Térreo, Brasília, DF, CEP: 70632-300, Brazil.
  • Daniele de Castro Félix
    Immunology Division, Sabin Diagnostic Medicine, SAAN QUADRA 03 Lote - 165 Térreo, Brasília, DF, CEP: 70632-300, Brazil.
  • Leandro Kegler Nardes
    Escola Superior de Ciências da Saúde-Curso de Medicina, Brasília, Brazil.
  • Igor Cabral Santos de Melo
    Unievangélica University, Anápolis, GO, Brazil.

Resumo

The prevalence of anti-cell autoantibodies detected by indirect immunofluorescence assay on HEp-2 cells (HEp-2-IIFA) increases with age and is higher in female sex. The number of medical specialties that use HEp-2-IIFA in the investigation of autoimmune diseases has increased lately. This study aimed to determine the prevalence and patterns of autoantibodies on HEp-2-IIFA according to demographics variables and referring medical specialties. A retrospective analysis of the HEp-2-IIFA carried out between January and June of 2017 was performed. The International Consensus on Antinuclear Antibodies Patterns (ICAP) and the Brazilian Consensus on Autoantibodies were used for patterns definition on visual reading of the slides. Anti-cell (AC) codes from ICAP and Brazilian AC codes (BAC) were used for patterns classification. From 54,990 samples referred for HEp-2-IIF testing, 20.9% were positive at titer ≥ 1/80. HEp-2-IIFA positivity in females and males was 24% and 12%, respectively (p < 0.0001). The proportion of positive results in the 4 age groups analyzed: 0-19, 20-39, 40-59, and ≥ 60 years was 23.3, 20.2, 20.1, and 22.8%, respectively (p < 0.0001). Considering all positive sera (n = 11,478), AC-4 nuclear fine speckled (37.7%), AC-2 nuclear dense fine speckled (21.3%), BAC-3 nuclear quasi-homogeneous (10%) and mixed/composite patterns (8.8%) were the most prevalent patterns. The specialties that most requested HEp-2-IIFA were general practitioner (20.1%), dermatology (15%), gynecology (9.9%), rheumatology (8.5%), and cardiology (5.8%). HEp-2-IIFA positivity was higher in patients referred by rheumatologists (35.7% vs. 19.6%) (p < 0.0001). Moderate (46.4%) and high (10.8%) titers were more observed in patients referred by rheumatologists (p < 0.0001). We observed a high proportion of mixed and cytoplasmic patterns in samples referred by oncologists and a high proportion of BAC-3 (nuclear quasi-homogeneous) pattern in samples referred by pneumologists. One-fifth of the patients studied were HEp-2-IIFA-positive. The age groups with more positive results were 0-19 and ≥ 60 years. AC-4, AC-2, BAC-3 and mixed/composite patterns were the most frequent patterns observed. Rheumatologists requested only 8.5% of HEp-2-IIFA. Positive results and moderate to high titers of autoantibodies were more frequent in patients referred by rheumatologists.

Utilizamos cookies para melhorar sua experiência. Ao navegar, você concorda com nossa Política de Privacidade. Ler Política

Painel de Acessibilidade

Ajuste sua experiência de navegação

LIBRAS

ASSISTÊNCIA VISUAL

Tamanho da Fonte

100%